-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on IceCure Medical Ltd. (ICCM)
-
-
-
-
-
-
-
IceCure Medical Ltd. (ICCM) PT Lowered to $2.50 at H.C. Wainwright
-
-
-
-
-
-
-
IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024
-
-
-
-
-
-
-
IceCure Medical Ltd (ICCM) Tops Q1 EPS by 1c
-
-
-
-
-
-
-
IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022
-
-
-
-
-
-
-
IceCure Medical Reports Financial Results as of and for the first Nine Months of 2021 and Recent Corporate Developments
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

